Neuroglobin Over Expressing Mice: Expression Pattern and Effect on Brain Ischemic Infarct Size

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Raida, Zindy ^a   Hundahl, Christian Ansgar ^b   Nyengaard, Jens R ^c   Hay Schmidt, Anders ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Faculty of Medicine   (Estonia)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ACTINS; ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBELLUM; CEREBRAL CORTEX; GENE EXPRESSION; GLOBINS; HIPPOCAMPUS; MALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PROMOTER REGIONS, GENETIC; SPECIES SPECIFICITY; TRANSGENES;

EID: 84885029621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076565     Document Type: Article

References (48)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Executive Summary: Heart Disease and Stroke Statistics-2013 Update: A Report From the American Heart Association. Circulation 127: 143-152.
2. The European Registers of Stroke (EROS) Investigators (2009) Incidence of Stroke in Europe at the Beginning of the 21st Century. Stroke 40: 1557-1563.
3. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, et al. (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113: e873-e923.
4. Truelsen T, Ekman M, Boysen G, (2005) Cost of stroke in Europe. Eur J Neurol 12Suppl 1: 78-84.
5. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, et al. (2001) Thrombolytic therapy for ischemic stroke-a review. Part I-Intravenous thrombolysis. Crit Care Med 29: 1812-1818.
6. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, et al. (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59: 467-477.
7. Moskowitz MA, Lo EH, Iadecola C, (2010) The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198.
8. Dietz GP, (2011) Protection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: a decade of research. Comment on Caiet al: TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol. 2011; 227(1): 224-31. Exp Neurol 231: 1-10.
9. Burmester T, Weich B, Reinhardt S, Hankeln T, (2000) A vertebrate globin expressed in the brain. Nature 407: 520-523.
10. Dewilde S, Kiger L, Burmester T, Hankeln T, Baudin-Creuza V, et al. (2001) Biochemical characterization and ligand binding properties of neuroglobin, a novel member of the globin family. J Biol Chem 276: 38949-38955.
11. Pesce A, Dewilde S, Nardini M, Moens L, Ascenzi P, et al. (2003) Human brain neuroglobin structure reveals a distinct mode of controlling oxygen affinity. Structure 11: 1087-1095.
12. Schmidt M, Giessl A, Laufs T, Hankeln T, Wolfrum U, et al. (2003) How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina. J Biol Chem 278: 1932-1935.
13. Fordel E, Thijs L, Martinet W, Schrijvers D, Moens L, et al. (2007) Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions. Gene 398: 114-122.
14. Fordel E, Thijs L, Moens L, Dewilde S, (2007) Neuroglobin and cytoglobin expression in mice. Evidence for a correlation with reactive oxygen species scavenging. FEBS J 274: 1312-1317.
15. Herold S, Fago A, Weber RE, Dewilde S, Moens L, (2004) Reactivity studies of the Fe(III) and Fe(II)NO forms of human neuroglobin reveal a potential role against oxidative stress. J Biol Chem 279: 22841-22847.
16. Brunori M, Giuffre A, Nienhaus K, Nienhaus GU, Scandurra FM, et al. (2005) Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes. Proc Natl Acad Sci U S A 102: 8483-8488.
17. Brittain T, (2012) The anti-apoptotic role of Neuroglobin. Cells 1: 1133-1155.
18. Gjedde A, Magistretti P (2011) Cellular Mechanisms of Brain Energy Metabolism. In: Youmans Neurological Surgery (Winn, H R, eds), Ed. Philadelphia, PA: 123-146.
19. Khan AA, Wang Y, Sun Y, Mao XO, Xie L, et al. (2006) Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc Natl Acad Sci U S A 103: 17944-17948.
20. Wang X, Liu J, Zhu H, Tejima E, Tsuji K, et al. (2008) Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia. Stroke 39: 1869-1874.
21. Sun Y, Jin K, Peel A, Mao XO, Xie L, et al. (2003) Neuroglobin protects the brain from experimental stroke in vivo. Proc Natl Acad Sci U S A 100: 3497-3500.
22. Li RC, Guo SZ, Lee SK, Gozal D, (2010) Neuroglobin protects neurons against oxidative stress in global ischemia. J Cereb Blood Flow Metab 30: 1874-1882.
23. Sun Y, Jin K, Mao XO, Zhu Y, Greenberg DA, (2001) Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc Natl Acad Sci U S A 98: 15306-15311.
24. Hundahl C, Kelsen J, Kjaer K, Ronn LC, Weber RE, et al. (2006) Does neuroglobin protect neurons from ischemic insult? A quantitative investigation of neuroglobin expression following transient MCAo in spontaneously hypertensive rats. Brain Res 1085: 19-27.
25. Schmidt-Kastner R, Haberkamp M, Schmitz C, Hankeln T, Burmester T, (2006) Neuroglobin mRNA expression after transient global brain ischemia and prolonged hypoxia in cell culture. Brain Res 1103: 173-180.
26. Raida Z, Hundahl CA, Kelsen J, Nyengaard JR, Hay-Schmidt A, (2012) Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo. Exp Transl Stroke Med 4: 15.
27. Hundahl CA, Luuk H, Ilmjarv S, Falktoft B, Raida Z, et al. (2011) Neuroglobin-deficiency exacerbates Hif1A and c-FOS response, but does not affect neuronal survival during severe hypoxia in vivo. PLoS One 6: e28160.
28. Hundahl CA, Fahrenkrug J, Luuk H, Hay-Schmidt A, Hannibal J, (2012) Restricted expression of Neuroglobin in the mouse retina and co-localization with Melanopsin and Tyrosine Hydroxylase. Biochem Biophys Res Commun 425: 100-106.
29. Hundahl CA, Kelsen J, Hay-Schmidt A, (2013) Neuroglobin and Cytoglobin expression in the human brain. Brain Struct Funct 218: 603-609.
30. Mammen PP, Shelton JM, Goetsch SC, Williams SC, Richardson JA, et al. (2002) Neuroglobin, a novel member of the globin family, is expressed in focal regions of the brain. J Histochem Cytochem 50: 1591-1598.
31. Institute for Laboratory Animal Research (2011) Guide for the care and use of laboratory animals. Washington (D.C), National Academies Press.
32. Khan AA, Sun Y, Jin K, Mao XO, Chen S, et al. (2007) A neuroglobin-overexpressing transgenic mouse. Gene 398: 172-176.
33. Hundahl CA, Allen GC, Hannibal J, Kjaer K, Rehfeld JF, et al. (2010) Anatomical characterization of cytoglobin and neuroglobin mRNA and protein expression in the mouse brain. Brain Res 1331: 58-73.
34. Raida Z, Reimets R, Hay-Schmidt A, Hundahl CA, (2012) Effect of permanent middle cerebral artery occlusion on Cytoglobin expression in the mouse brain. Biochem Biophys Res Commun 424: 274-278.
35. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
36. Eberspacher E, Eckel B, Engelhard K, Muller K, Hoffman WE, et al. (2009) Effects of sevoflurane on cognitive deficit, motor function, and histopathology after cerebral ischemia in rats. Acta Anaesthesiol Scand 53: 774-782.
37. Gundersen HJ, (1988) The nucleator. J Microsc 151: 3-21.
38. Lee HM, Greeley GH Jr, Englander EW, (2011) Transgenic overexpression of neuroglobin attenuates formation of smoke-inhalation-induced oxidative DNA damage, in vivo, in the mouse brain. Free Radic Biol Med 51: 2281-2287.
39. Williams RS, Wagner PD, (2000) Transgenic animals in integrative biology: approaches and interpretations of outcome. J Appl Physiol 88: 1119-1126.
40. Davis J, Maillet M, Miano JM, Molkentin JD, (2012) Lost in transgenesis: a user's guide for genetically manipulating the mouse in cardiac research. Circ Res 111: 761-777.
41. Majid A, He YY, Gidday JM, Kaplan SS, Gonzales ER, et al. (2000) Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke 31: 2707-2714.
42. Wang S, Zhang H, Dai X, Sealock R, Faber JE, (2010) Genetic architecture underlying variation in extent and remodeling of the collateral circulation. Circ Res 107: 558-568.
43. Zhang H, Prabhakar P, Sealock R, Faber JE, (2010) Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab 30: 923-934.
44. Ward R, Collins RL, Tanguay G, Miceli D, (1990) A quantitative study of cerebrovascular variation in inbred mice. J Anat 173: 87-95.
45. Yang G, Kitagawa K, Matsushita K, Mabuchi T, Yagita Y, et al. (1997) C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Res 752: 209-218.
46. Carmichael ST, (2005) Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2: 396-409.
47. Steward O, Schauwecker PE, Guth L, Zhang Z, Fujiki M, et al. (1999) Genetic approaches to neurotrauma research: opportunities and potential pitfalls of murine models. Exp Neurol 157: 19-42.
48. Ward R, (1985) Genetic polymorphisms and additive genetic models. Behav Genet 15: 537-548.